🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/05/2000 | 0,2767 USD |
| 01/03/2000 | 0,2767 USD |
| 01/12/1999 | 0,2767 USD |
| 01/09/1999 | 0,2767 USD |
| 02/06/1999 | 0,2576 USD |
| 03/03/1999 | 0,2576 USD |
| 02/12/1998 | 0,2576 USD |
| 02/09/1998 | 0,2576 USD |
| 03/06/1998 | 0,2147 USD |
| 04/03/1998 | 0,2147 USD |
| 03/12/1997 | 0,2147 USD |
| 03/09/1997 | 0,2147 USD |
| 05/06/1997 | 0,2004 USD |
| 05/03/1997 | 0,2004 USD |
| 05/12/1996 | 0,1908 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 02/11/2017 | 52,94 | 53,02 | 52,52 | 52,83 | +0,05% | 0,96% | 12.909.788 |
| 01/11/2017 | 53,00 | 53,24 | 52,75 | 52,81 | +0,45% | 0,94% | 17.206.483 |
| 31/10/2017 | 52,64 | 53,23 | 52,51 | 52,57 | +0,69% | 1,38% | 19.313.802 |
| 30/10/2017 | 53,20 | 53,48 | 51,92 | 52,20 | -6,06% | 2,94% | 40.860.891 |
| 27/10/2017 | 57,78 | 57,78 | 55,17 | 55,57 | -6,05% | 4,51% | 30.980.242 |
| 26/10/2017 | 59,44 | 59,82 | 58,98 | 59,15 | -0,74% | 1,41% | 11.260.026 |
| 25/10/2017 | 60,21 | 60,24 | 59,48 | 59,59 | -1,05% | 1,27% | 11.545.502 |
| 24/10/2017 | 60,41 | 60,41 | 59,51 | 60,22 | -0,46% | 1,48% | 10.711.713 |
| 23/10/2017 | 61,10 | 61,56 | 60,40 | 60,50 | -0,75% | 1,91% | 12.137.936 |
| 20/10/2017 | 60,93 | 61,06 | 60,66 | 60,95 | +0,20% | 0,66% | 10.798.802 |
| 19/10/2017 | 60,73 | 61,10 | 60,68 | 60,83 | +0,38% | 0,69% | 10.554.618 |
| 18/10/2017 | 61,15 | 61,17 | 60,51 | 60,60 | +0,46% | 1,09% | 8.265.471 |
| 17/10/2017 | 60,31 | 60,41 | 60,00 | 60,32 | -0,19% | 0,68% | 7.365.868 |
| 16/10/2017 | 60,58 | 60,81 | 60,36 | 60,44 | -0,08% | 0,74% | 7.806.762 |
| 13/10/2017 | 61,02 | 61,22 | 60,48 | 60,49 | -0,69% | 1,22% | 7.693.787 |
| 12/10/2017 | 60,87 | 61,05 | 60,65 | 60,91 | +0,08% | 0,66% | 6.454.108 |
| 11/10/2017 | 61,39 | 61,39 | 60,86 | 60,86 | -1,05% | 0,87% | 10.586.477 |
| 10/10/2017 | 61,36 | 61,52 | 61,25 | 61,51 | +0,20% | 0,44% | 5.157.208 |
| 09/10/2017 | 61,71 | 61,77 | 61,18 | 61,38 | -0,34% | 0,96% | 5.712.962 |
| 06/10/2017 | 61,74 | 61,93 | 61,42 | 61,59 | -0,08% | 0,82% | 7.847.843 |
| 05/10/2017 | 61,47 | 61,83 | 61,38 | 61,64 | +0,00% | 0,73% | 9.589.200 |
| 04/10/2017 | 61,47 | 61,66 | 61,38 | 61,64 | +0,36% | 0,45% | 6.722.606 |
| 03/10/2017 | 61,59 | 61,62 | 60,86 | 61,42 | -0,28% | 1,24% | 6.819.441 |
| 02/10/2017 | 61,27 | 61,72 | 60,96 | 61,59 | +0,81% | 1,23% | 7.067.083 |
| 29/09/2017 | 61,35 | 61,57 | 60,43 | 61,10 | -0,40% | 1,87% | 11.999.181 |
| 28/09/2017 | 61,33 | 61,70 | 61,23 | 61,35 | -0,43% | 0,76% | 7.359.894 |
| 27/09/2017 | 61,72 | 61,78 | 61,37 | 61,61 | -0,29% | 0,66% | 7.013.111 |
| 26/09/2017 | 62,12 | 62,33 | 61,76 | 61,79 | -0,64% | 0,92% | 7.311.058 |
| 25/09/2017 | 62,18 | 62,40 | 62,06 | 62,19 | +0,08% | 0,55% | 5.840.923 |
| 22/09/2017 | 62,62 | 62,69 | 62,09 | 62,15 | -0,72% | 0,96% | 7.824.263 |